OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in natural killer cell therapies for breast cancer
Seyedeh Zahra Fotook Kiaei, Alireza Nouralishahi, Mohammad Ghasemirad, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 8, pp. 705-726
Open Access | Times Cited: 14
Seyedeh Zahra Fotook Kiaei, Alireza Nouralishahi, Mohammad Ghasemirad, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 8, pp. 705-726
Open Access | Times Cited: 14
Showing 14 citing articles:
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo
Vita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13364-13364
Open Access | Times Cited: 23
Vita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13364-13364
Open Access | Times Cited: 23
The Tumor Immune Microenvironment in Breast Cancer Progression
Marit Otterlei Fjørtoft, Kanutte Huse, Inga H. Rye
Acta Oncologica (2024) Vol. 63, pp. 359-367
Open Access | Times Cited: 5
Marit Otterlei Fjørtoft, Kanutte Huse, Inga H. Rye
Acta Oncologica (2024) Vol. 63, pp. 359-367
Open Access | Times Cited: 5
From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
Fatemah Basingab, Omniah A. Alshahrani, Ibtehal AlAnsari, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 27-51
Open Access
Fatemah Basingab, Omniah A. Alshahrani, Ibtehal AlAnsari, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 27-51
Open Access
The drug delivery of methimazole through the sensing function assessments of BeO fullerene-like particles: DFT study
Mounir M. Salem‐Bekhit, Miao Dai, М. М. Рахматуллаева, et al.
Chemical Physics Impact (2023) Vol. 7, pp. 100335-100335
Open Access | Times Cited: 14
Mounir M. Salem‐Bekhit, Miao Dai, М. М. Рахматуллаева, et al.
Chemical Physics Impact (2023) Vol. 7, pp. 100335-100335
Open Access | Times Cited: 14
Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity
Tatiana S. Gerashchenko, A. A. Frolova, М. Р. Патышева, et al.
Advanced Biology (2024) Vol. 8, Iss. 7
Closed Access | Times Cited: 3
Tatiana S. Gerashchenko, A. A. Frolova, М. Р. Патышева, et al.
Advanced Biology (2024) Vol. 8, Iss. 7
Closed Access | Times Cited: 3
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 1
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 1
Targeting Myeloid Determinants of Breast Cancer
Chie Kudo‐Saito, Yukinori Ozaki
(2024), pp. 255-285
Closed Access
Chie Kudo‐Saito, Yukinori Ozaki
(2024), pp. 255-285
Closed Access
Resistance to Immunotherapy in Breast Cancer
Botle Precious Damane, Lorraine Tshegofatso Maebele, Malose Makgoka, et al.
(2024), pp. 83-103
Closed Access
Botle Precious Damane, Lorraine Tshegofatso Maebele, Malose Makgoka, et al.
(2024), pp. 83-103
Closed Access
Natural products as promising modulators of breast cancer immunotherapy
Aljawharah Alqathama
Frontiers in Immunology (2024) Vol. 15
Open Access
Aljawharah Alqathama
Frontiers in Immunology (2024) Vol. 15
Open Access
Unveiling immunological and prognostic potential of FBXO2 in BC based on Pan-Cancer and Single cell analyses
Min Mao, Rongzhi Huang, Shenglian Lai
Research Square (Research Square) (2024)
Closed Access
Min Mao, Rongzhi Huang, Shenglian Lai
Research Square (Research Square) (2024)
Closed Access
Three-Dimensional Model Analysis Revealed Differential Cytotoxic Effects of the NK-92 Cell Line and Primary NK Cells on Breast and Ovarian Carcinoma Cell Lines Mediated by Variations in Receptor–Ligand Interactions and Soluble Factor Profiles
Nadezhda A. Alekseeva, Anna A. Boyko, Marina A. Shevchenko, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2398-2398
Open Access
Nadezhda A. Alekseeva, Anna A. Boyko, Marina A. Shevchenko, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2398-2398
Open Access
Immunoglobulin-binding protein and Toll-like receptors in immune landscape of breast cancer
Priyamvada Bhamidipati, Ganji Purnachandra Nagaraju, Rama Rao Malla
Life Sciences (2024), pp. 123196-123196
Closed Access
Priyamvada Bhamidipati, Ganji Purnachandra Nagaraju, Rama Rao Malla
Life Sciences (2024), pp. 123196-123196
Closed Access
Delineation of hub genes related to ferroptosis and radiosensitivity in breast cancer with three identified subtypes
Mao Mao, Yichao Zhuang, Haitao Yu
Computer Methods in Biomechanics & Biomedical Engineering (2024), pp. 1-16
Closed Access
Mao Mao, Yichao Zhuang, Haitao Yu
Computer Methods in Biomechanics & Biomedical Engineering (2024), pp. 1-16
Closed Access
Cryoablation of primary breast cancer tumors induces a systemic abscopal effect altering TIME (Tumor Immune Microenvironment) in distant tumors
Flávia Sardela de Miranda, Dalia Martinez‐Marin, Rachel L. Babcock, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Flávia Sardela de Miranda, Dalia Martinez‐Marin, Rachel L. Babcock, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
